REXULTI BREXPIPRAZOLE

Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 21 Sept 2022)

What this means for you

Registered since 04 Oct 2016. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
86662242
Registration number
5052422
Mark type
Design + words
Filed
15 Jun 2015
Published for opposition
19 Jul 2016
Registered
04 Oct 2016
Attorney of record
Scott S. Havlick

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of depression and schizophrenia; all of the foregoing containing brexpiprazole

Owner

Prior registrations

Prosecution history

  • 04 Oct 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
  • 21 Sept 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
  • 21 Sept 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
  • 21 Sept 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 25 Mar 2022 — TEAS SECTION 8 & 15 RECEIVED
  • 04 Oct 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 04 Oct 2016 — REGISTERED-PRINCIPAL REGISTER
  • 19 Jul 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 19 Jul 2016 — PUBLISHED FOR OPPOSITION
  • 29 Jun 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 09 Jun 2016 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 05 Mar 2016 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
  • 04 Mar 2016 — USE AMENDMENT ACCEPTED
  • 04 Mar 2016 — DATA MODIFICATION COMPLETED
  • 04 Mar 2016 — AMENDMENT TO USE PROCESSING COMPLETE

View this trademark record on Marksy